Cargando…
EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting
Cervical cancer is a major cause of cancer death in women worldwide. Targeting human papillomavirus (HPV) viral oncoproteins E6 and E7 is a new strategy for cervical cancer immunotherapy and has been associated with resolution of HPV-induced lesions. How to efficiently induce T cell target killing o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965802/ https://www.ncbi.nlm.nih.gov/pubmed/36851198 http://dx.doi.org/10.3390/vaccines11020320 |
_version_ | 1784896856260608000 |
---|---|
author | Feng, Juan Liu, Yongliang Zhuang, Na Chai, Zixuan Liu, Limei Qian, Cheng Li, Jiatao Shan, Juanjuan |
author_facet | Feng, Juan Liu, Yongliang Zhuang, Na Chai, Zixuan Liu, Limei Qian, Cheng Li, Jiatao Shan, Juanjuan |
author_sort | Feng, Juan |
collection | PubMed |
description | Cervical cancer is a major cause of cancer death in women worldwide. Targeting human papillomavirus (HPV) viral oncoproteins E6 and E7 is a new strategy for cervical cancer immunotherapy and has been associated with resolution of HPV-induced lesions. How to efficiently induce T cell target killing of HPV infected cervical cancer is of great potential benefit for cervical cancer treatment. Fusion protein containing the extra domain A (EDA) from fibronectin, a natural ligand for Toll-like receptor 4 (TLR4), and HPVE7 (EDA-E7) has been shown to efficiently induce dendritic cells maturation and trigger specific antitumor CD8+ T cells response in mice. In this study, we constructed EDA-E7 fusion protein of human origin and tested its function in dendritic cell maturation as well as antitumor T cell response. We found that EDA-E7 could be efficiently captured by human PBMC derived dendritic cells (DCs) in vitro and induce DCs maturation. Importantly, this effect could work in synergy with the TLR ligand anti-CD40 agonist, polyinosinic-polycytidylic acid [poly (I:C)], R848, and CpG2216. EDA-E7 matured DCs could activate T cells and trigger an anti-tumor response in vitro. Single cell RNA sequencing and T cell targeted killing assay confirmed the activation of T cells by EDA-E7 matured DCs. Therefore, therapeutic vaccination with EDA-E7 fusion protein maybe effective for human cervical carcinoma treatment. |
format | Online Article Text |
id | pubmed-9965802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99658022023-02-26 EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting Feng, Juan Liu, Yongliang Zhuang, Na Chai, Zixuan Liu, Limei Qian, Cheng Li, Jiatao Shan, Juanjuan Vaccines (Basel) Article Cervical cancer is a major cause of cancer death in women worldwide. Targeting human papillomavirus (HPV) viral oncoproteins E6 and E7 is a new strategy for cervical cancer immunotherapy and has been associated with resolution of HPV-induced lesions. How to efficiently induce T cell target killing of HPV infected cervical cancer is of great potential benefit for cervical cancer treatment. Fusion protein containing the extra domain A (EDA) from fibronectin, a natural ligand for Toll-like receptor 4 (TLR4), and HPVE7 (EDA-E7) has been shown to efficiently induce dendritic cells maturation and trigger specific antitumor CD8+ T cells response in mice. In this study, we constructed EDA-E7 fusion protein of human origin and tested its function in dendritic cell maturation as well as antitumor T cell response. We found that EDA-E7 could be efficiently captured by human PBMC derived dendritic cells (DCs) in vitro and induce DCs maturation. Importantly, this effect could work in synergy with the TLR ligand anti-CD40 agonist, polyinosinic-polycytidylic acid [poly (I:C)], R848, and CpG2216. EDA-E7 matured DCs could activate T cells and trigger an anti-tumor response in vitro. Single cell RNA sequencing and T cell targeted killing assay confirmed the activation of T cells by EDA-E7 matured DCs. Therefore, therapeutic vaccination with EDA-E7 fusion protein maybe effective for human cervical carcinoma treatment. MDPI 2023-01-31 /pmc/articles/PMC9965802/ /pubmed/36851198 http://dx.doi.org/10.3390/vaccines11020320 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Feng, Juan Liu, Yongliang Zhuang, Na Chai, Zixuan Liu, Limei Qian, Cheng Li, Jiatao Shan, Juanjuan EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting |
title | EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting |
title_full | EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting |
title_fullStr | EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting |
title_full_unstemmed | EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting |
title_short | EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting |
title_sort | eda-e7 activated dcs induces cytotoxic t lymphocyte immune responses against hpv expressing cervical cancer in human setting |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965802/ https://www.ncbi.nlm.nih.gov/pubmed/36851198 http://dx.doi.org/10.3390/vaccines11020320 |
work_keys_str_mv | AT fengjuan edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting AT liuyongliang edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting AT zhuangna edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting AT chaizixuan edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting AT liulimei edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting AT qiancheng edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting AT lijiatao edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting AT shanjuanjuan edae7activateddcsinducescytotoxictlymphocyteimmuneresponsesagainsthpvexpressingcervicalcancerinhumansetting |